Pfizer Supply Chain
Supply Chain of Pfizer (PFE) as of Oct 10, 2026.
Get this data via API
Financial Data API
Supply Chain
-
Last updated:
Supply chains in stock corporations are essential components of business infrastructure and play a crucial role in value creation and competitiveness. These supply chains encompass all steps from raw material procurement and production to the delivery of finished products to the end customer.
Pfizer Supply Chain
Correlation: how closely stock prices move together
Same directionNo relationOpposite
250 companies
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | 0.42 | 0.88 | 0.94 | ||
| 2 | 0.60 | 0.77 | 0.91 | ||
| 3 | 0.50 | 0.85 | 0.89 | ||
| 4 | 0.36 | 0.79 | 0.89 | ||
| 5 | 0.38 | 0.74 | 0.88 | ||
| 6 | 0.66 | 0.74 | 0.87 | ||
| 7 | 0.71 | 0.80 | 0.86 | ||
| 8 | -0.20 | 0.64 | 0.83 | ||
| 9 | -0.44 | 0.62 | 0.83 | ||
| 10 | -0.28 | 0.60 | 0.81 | ||
| 11 | -0.11 | 0.47 | 0.81 | ||
| 12 | 0.37 | 0.42 | 0.81 | ||
| 13 | 0.42 | 0.31 | 0.81 | ||
| 14 | -0.39 | 0.57 | 0.80 | ||
| 15 | -0.45 | 0.50 | 0.80 | ||
| 16 | 0.59 | 0.63 | 0.79 | ||
| 17 | 0.63 | 0.64 | 0.79 | ||
| 18 | 0.53 | 0.30 | 0.79 | ||
| 19 | -0.22 | 0.40 | 0.78 | ||
| 20 | 0.04 | -0.08 | 0.77 | ||
| 21 | HSIL | -0.19 | 0.30 | 0.77 | |
| 22 | -0.47 | 0.35 | 0.77 | ||
| 23 | 0.54 | 0.32 | 0.77 | ||
| 24 | Biotest Vz I | 0.43 | 0.07 | 0.77 | |
| 25 | 0.39 | 0.70 | 0.77 | ||
| 26 | 0.58 | 0.26 | 0.75 | ||
| 27 | -0.46 | 0.25 | 0.74 | ||
| 28 | 0.10 | 0.06 | 0.74 | ||
| 29 | 0.46 | 0.13 | 0.73 | ||
| 30 | 0.39 | 0.08 | 0.73 | ||
| 31 | 0.19 | -0.16 | 0.73 | ||
| 32 | 0.82 | 0.10 | 0.73 | ||
| 33 | 0.18 | 0.32 | 0.71 | ||
| 34 | 0.53 | 0.53 | 0.71 | ||
| 35 | Insignia Systems | 0.71 | 0.64 | 0.70 | |
| 36 | -0.33 | 0.40 | 0.70 | ||
| 37 | 0.19 | -0.26 | 0.69 | ||
| 38 | 0.59 | 0.27 | 0.69 | ||
| 39 | Issuer Direct | 0.35 | 0.30 | 0.69 | |
| 40 | -0.12 | 0.71 | 0.68 | ||
| 41 | Owens & Minor | 0.34 | 0.12 | 0.65 | |
| 42 | 0.04 | 0.70 | 0.64 | ||
| 43 | 0.05 | -0.45 | 0.64 | ||
| 44 | 0.25 | 0.57 | 0.63 | ||
| 45 | -0.09 | 0.04 | 0.62 | ||
| 46 | -0.07 | 0 | 0.62 | ||
| 47 | 0.24 | 0.56 | 0.61 | ||
| 48 | 0.46 | -0.10 | 0.60 | ||
| 49 | 0.31 | -0.33 | 0.60 | ||
| 50 | 0.16 | 0.67 | 0.60 | ||
| 51 | 0.38 | -0.14 | 0.57 | ||
| 52 | 0.34 | -0.42 | 0.57 | ||
| 53 | 0.12 | 0.20 | 0.57 | ||
| 54 | -0.16 | 0.22 | 0.56 | ||
| 55 | -0.25 | 0.41 | 0.55 | ||
| 56 | Aukett Swanke Group | 0.28 | 0.26 | 0.50 | |
| 57 | 0.24 | -0.42 | 0.48 | ||
| 58 | -0.39 | 0.18 | 0.44 | ||
| 59 | -0.20 | 0.29 | 0.43 | ||
| 60 | -0.32 | 0.13 | 0.43 | ||
| 61 | 0.54 | 0.27 | 0.43 | ||
| 62 | -0.14 | 0.14 | 0.42 | ||
| 63 | 0.36 | -0.55 | 0.42 | ||
| 64 | 0.41 | -0.38 | 0.41 | ||
| 65 | 0.40 | -0.51 | 0.40 | ||
| 66 | 0.42 | -0.59 | 0.38 | ||
| 67 | 0.44 | -0.09 | 0.36 | ||
| 68 | 0.26 | -0.33 | 0.36 | ||
| 69 | -0.38 | 0.31 | 0.36 | ||
| 70 | 0.36 | -0.63 | 0.34 | ||
| 71 | 0.43 | -0.47 | 0.34 | ||
| 72 | Nolato B | 0.43 | -0.19 | 0.34 | |
| 73 | 0.33 | -0.18 | 0.32 | ||
| 74 | 0.20 | -0.01 | 0.31 | ||
| 75 | 0.30 | -0.30 | 0.31 |
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | — | — | — | ||
| 2 | 0.08 | -0.54 | — | ||
| 3 | -0.07 | 0.57 | — | ||
| 4 | 0.07 | -0.75 | — | ||
| 5 | 0.58 | -0.73 | — | ||
| 6 | Takeda Pharmaceutical Company Limited | -0.11 | -0.78 | — | |
| 7 | Alfresa Holdings Corporation | — | — | — | |
| 8 | WPP plc | 0.01 | — | — | |
| 9 | UCB SA | — | — | — | |
| 10 | Eisai Co., Ltd. | — | — | — | |
| 11 | Asymchem Laboratories (Tianjin) H | — | — | — | |
| 12 | -0.39 | — | — | ||
| 13 | Publicis Groupe S.A. | -0.01 | — | — | |
| 14 | Sodexo S.A. | 0.36 | — | — | |
| 15 | -0.04 | 0.18 | — | ||
| 16 | LianBio ADR | 0.28 | — | — | |
| 17 | MediPal Holdings Corporation | — | — | — | |
| 18 | 0.36 | — | — | ||
| 19 | Coland Holdings Ltd. | — | — | — | |
| 20 | ECMOHO Sp ADS-A | 0.43 | -0.77 | — | |
| 21 | 0.53 | -0.43 | — | ||
| 22 | -0.54 | 0.63 | — | ||
| 23 | 0.56 | -0.38 | — | ||
| 24 | 0.33 | -0.66 | — | ||
| 25 | SourceBio International | 0.64 | -0.20 | — | |
| 26 | 0.54 | -0.45 | — | ||
| 27 | 0.04 | -0.75 | — | ||
| 28 | Valneva SE | 0.62 | 0.55 | — | |
| 29 | Fitbit, Inc. | -0.55 | — | — | |
| 30 | 0.52 | — | — | ||
| 31 | -0.35 | -0.48 | — | ||
| 32 | Astellas Pharma Inc. | 0.48 | — | — | |
| 33 | 0.38 | -0.76 | — | ||
| 34 | 0.32 | 0.09 | — | ||
| 35 | — | — | — | ||
| 36 | 0.34 | -0.67 | — | ||
| 37 | -0.32 | -0.21 | — | ||
| 38 | -0.12 | -0.10 | — | ||
| 39 | 0.36 | -0.82 | — | ||
| 40 | Sanofi | -0.41 | 0.11 | — | |
| 41 | 0.02 | 0.08 | — | ||
| 42 | 0.59 | — | — | ||
| 43 | 0.58 | 0.52 | — | ||
| 44 | -0.13 | 0.53 | — | ||
| 45 | Meltwater | 0.51 | -0.72 | — | |
| 46 | 0.36 | -0.80 | -0.89 | ||
| 47 | 0.13 | -0.79 | -0.89 | ||
| 48 | 0.39 | -0.65 | -0.89 | ||
| 49 | 0.48 | -0.74 | -0.88 | ||
| 50 | 0.51 | -0.73 | -0.88 | ||
| 51 | 0.14 | -0.77 | -0.88 | ||
| 52 | 0.41 | -0.78 | -0.86 | ||
| 53 | Centogene | 0.46 | -0.79 | -0.84 | |
| 54 | 0 | -0.58 | -0.84 | ||
| 55 | 0.49 | -0.77 | -0.83 | ||
| 56 | Homology Meds | 0.27 | -0.68 | -0.83 | |
| 57 | 0.58 | -0.68 | -0.83 | ||
| 58 | Clovis Oncology, Inc. | 0.57 | -0.74 | -0.82 | |
| 59 | 0.25 | -0.74 | -0.82 | ||
| 60 | 0.35 | -0.39 | -0.82 | ||
| 61 | 0.47 | -0.39 | -0.81 | ||
| 62 | -0.18 | -0.70 | -0.81 | ||
| 63 | Nicox | 0.55 | -0.65 | -0.81 | |
| 64 | 0.54 | -0.49 | -0.80 | ||
| 65 | 0.49 | -0.55 | -0.79 | ||
| 66 | 0.57 | -0.64 | -0.79 | ||
| 67 | -0.65 | -0.25 | -0.79 | ||
| 68 | 0.44 | -0.74 | -0.78 | ||
| 69 | 0.14 | -0.81 | -0.77 | ||
| 70 | -0.19 | -0.77 | -0.76 | ||
| 71 | 0.56 | -0.67 | -0.76 | ||
| 72 | 0.53 | -0.59 | -0.74 | ||
| 73 | 0.31 | -0.71 | -0.73 | ||
| 74 | 0.44 | -0.60 | -0.73 | ||
| 75 | -0.28 | -0.31 | -0.73 | ||
| 76 | 0.45 | -0.46 | -0.72 | ||
| 77 | 0.56 | -0.47 | -0.71 | ||
| 78 | 0.01 | -0.79 | -0.70 | ||
| 79 | 0.19 | -0.61 | -0.69 | ||
| 80 | 0.24 | -0.75 | -0.69 | ||
| 81 | 0.33 | -0.76 | -0.69 | ||
| 82 | 0.61 | -0.40 | -0.68 | ||
| 83 | 0.15 | -0.73 | -0.67 | ||
| 84 | 0.48 | -0.71 | -0.65 | ||
| 85 | -0.25 | 0.01 | -0.65 | ||
| 86 | 0.49 | -0.72 | -0.64 | ||
| 87 | 0.05 | -0.69 | -0.64 | ||
| 88 | 0.18 | -0.66 | -0.63 | ||
| 89 | -0.42 | 0.30 | -0.61 | ||
| 90 | ADL Bionatur Solutions | 0.59 | -0.42 | -0.60 | |
| 91 | 0.15 | -0.76 | -0.60 | ||
| 92 | 0.43 | -0.12 | -0.59 | ||
| 93 | 0.54 | -0.56 | -0.59 | ||
| 94 | 0.44 | -0.75 | -0.57 | ||
| 95 | 0.51 | 0.05 | -0.57 | ||
| 96 | -0.47 | 0.14 | -0.56 | ||
| 97 | 0.51 | -0.61 | -0.56 | ||
| 98 | Aslan Pharmaceuticals ADR | 0.43 | -0.71 | -0.56 | |
| 99 | 0.57 | -0.44 | -0.56 | ||
| 100 | 0.55 | -0.57 | -0.55 | ||
| 101 | 0.43 | -0.27 | -0.55 | ||
| 102 | 0.31 | -0.24 | -0.54 | ||
| 103 | 0.03 | -0.25 | -0.53 | ||
| 104 | 0.08 | -0.52 | -0.53 | ||
| 105 | -0.31 | 0.04 | -0.52 | ||
| 106 | 0.35 | -0.66 | -0.52 | ||
| 107 | 0.44 | -0.79 | -0.51 | ||
| 108 | 0.37 | -0.47 | -0.50 | ||
| 109 | 0.25 | -0.58 | -0.48 | ||
| 110 | 0.52 | -0.56 | -0.47 | ||
| 111 | 0.23 | 0.06 | -0.47 | ||
| 112 | 0.55 | -0.51 | -0.46 | ||
| 113 | 0.13 | -0.68 | -0.46 | ||
| 114 | 0.67 | -0.54 | -0.45 | ||
| 115 | 0.51 | -0.68 | -0.44 | ||
| 116 | 0.66 | -0.74 | -0.44 | ||
| 117 | Aarti Drugs | 0.62 | -0.74 | -0.44 | |
| 118 | 0.17 | -0.54 | -0.43 | ||
| 119 | -0.01 | -0.66 | -0.42 | ||
| 120 | 0.46 | -0.60 | -0.42 | ||
| 121 | 0.45 | -0.05 | -0.42 | ||
| 122 | 0.39 | -0.60 | -0.42 | ||
| 123 | 0.82 | -0.24 | -0.41 | ||
| 124 | 0.20 | -0.42 | -0.35 | ||
| 125 | 0.36 | -0.70 | -0.35 | ||
| 126 | 0.45 | -0.41 | -0.34 | ||
| 127 | 0.42 | -0.67 | -0.34 | ||
| 128 | 0.18 | -0.64 | -0.33 | ||
| 129 | 0.64 | -0.19 | -0.31 | ||
| 130 | Hindusthan National Glass | 0.74 | -0.57 | -0.29 | |
| 131 | 0.50 | -0.80 | -0.26 | ||
| 132 | -0.33 | 0.57 | -0.26 | ||
| 133 | 0.20 | -0.73 | -0.25 | ||
| 134 | 0.23 | -0.30 | -0.23 | ||
| 135 | -0.22 | -0.64 | -0.22 | ||
| 136 | 0.45 | -0.64 | -0.21 | ||
| 137 | 0.44 | -0.10 | -0.21 | ||
| 138 | 0.41 | -0.02 | -0.19 | ||
| 139 | -0.03 | -0.72 | -0.14 | ||
| 140 | 0.18 | -0.63 | -0.12 | ||
| 141 | -0.10 | 0.27 | -0.11 | ||
| 142 | 0.39 | -0.76 | -0.11 | ||
| 143 | Zydus Lifesciences | 0.59 | -0.73 | -0.09 | |
| 144 | -0.11 | 0.01 | -0.03 | ||
| 145 | 0.49 | -0.20 | -0.02 | ||
| 146 | 0.52 | -0.64 | -0.01 | ||
| 147 | -0.22 | -0.02 | -0.01 | ||
| 148 | Pfizer Ltd /India | 0.59 | -0.61 | 0.01 | |
| 149 | -0.38 | 0.39 | 0.02 | ||
| 150 | 0.28 | -0.23 | 0.02 | ||
| 151 | 0.43 | -0.12 | 0.03 | ||
| 152 | 0.42 | -0.23 | 0.03 | ||
| 153 | 0.68 | -0.04 | 0.06 | ||
| 154 | 0.42 | -0.46 | 0.06 | ||
| 155 | -0.09 | 0.03 | 0.06 | ||
| 156 | -0.13 | -0.47 | 0.06 | ||
| 157 | Bausch Health Companies Inc. | 0.50 | -0.38 | 0.07 | |
| 158 | 0.44 | 0.48 | 0.07 | ||
| 159 | -0.02 | -0.48 | 0.07 | ||
| 160 | 0.50 | -0.38 | 0.08 | ||
| 161 | 0.04 | -0.24 | 0.08 | ||
| 162 | -0.56 | -0.25 | 0.11 | ||
| 163 | -0.50 | 0.24 | 0.13 | ||
| 164 | 0.38 | -0.41 | 0.16 | ||
| 165 | 0.02 | -0.60 | 0.16 | ||
| 166 | 0.39 | -0.61 | 0.17 | ||
| 167 | 0.37 | -0.58 | 0.17 | ||
| 168 | -0.24 | 0.20 | 0.17 | ||
| 169 | 0.19 | -0.32 | 0.18 | ||
| 170 | -0.40 | -0.35 | 0.21 | ||
| 171 | 0.40 | -0.61 | 0.23 | ||
| 172 | 0.45 | 0.29 | 0.23 | ||
| 173 | 0.64 | -0.20 | 0.23 | ||
| 174 | -0.35 | -0.14 | 0.26 | ||
| 175 | -0.19 | 0.13 | 0.28 |
Access this data via the Eulerpool API
Pfizer Stock analysis
What does Pfizer do? Pfizer Inc, one of the world's largest and most well-known pharmaceutical companies, has made significant advancements in the medical industry throughout its approximately 170-year history. The company is headquartered in New York City and has offices in over 150 countries.
Pfizer was founded in 1849 by two cousins, Charles Pfizer and Charles Erhart, who opened their first factory in Brooklyn to produce pure crystalline chinasalt. They later expanded their business and began synthesizing chemical compounds, leading them to enter the pharmaceutical industry.
In the following years, Pfizer made some significant discoveries, including the synthesis of antibiotics such as penicillin and terramycin. In the 1990s, the company expanded its portfolio and became a leading provider of prescription drugs, immunological medications, and animal health products.
Today, the company focuses on three core areas: innovative health products, patented medications, and generic products. Pfizer invests millions of dollars in research and development of new and innovative treatment options, including cancer drugs, therapies for neurological disorders, cardiovascular diseases, and immunology products.
Another important aspect of Pfizer's business model is its partnerships with other companies and organizations. The company works closely with universities, research institutions, governments, and other companies to form partnerships that allow for collaborative development of new products.
Some of Pfizer's most well-known products include Viagra, Lipitor, Celebrex, Zoloft, and Lyrica. Viagra is used to treat erectile dysfunction in men. Lipitor is a cholesterol-lowering medication that reduces the risk of cardiovascular diseases. Celebrex is an anti-inflammatory medication used to treat pain and inflammation. Zoloft is an antidepressant used to treat various mental disorders. Lyrica is a prescription medication used to treat pain and seizures.
In recent years, Pfizer has also taken a leading role in the development of vaccines against COVID-19, collaborating with the German company BioNTech to develop a promising vaccine candidate. The vaccine provides protection against the virus, particularly against severe illness.
Over the years, the company has faced concerns regarding the use of medications, such as the scandal surrounding the pain reliever Vioxx, which was withdrawn in 2004 after being associated with an increased risk of cardiovascular diseases. Pfizer has since strengthened its research and development standards and partnerships to ensure the safety and efficacy of its products.
In summary, Pfizer is a global player in the pharmaceutical industry. The company heavily invests in research and development of new products to provide innovative treatment options, secures patents, and simultaneously keeps its portfolio up-to-date with generic products to remain competitive in the industry. The company will continue to contribute to improving healthcare worldwide by developing lifesaving medications and vaccines that enable people to lead better lives. Pfizer is one of the most popular companies on Eulerpool.
All Key Metrics — Pfizer
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth